Acquired Drug Resistance: We Can Do More Than We Think!

被引：17
作者：
Alffenaar, Jan-Willem C. [1 ]
Gumbo, Tawanda [2 ]
Aarnoutse, Rob E. [3 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 AB Groningen, Netherlands
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, NL-6525 ED Nijmegen, Netherlands
来源：
CLINICAL INFECTIOUS DISEASES | 2015年 / 60卷 / 06期
关键词：
PHARMACOKINETIC VARIABILITY; TUBERCULOUS MENINGITIS; MOXIFLOXACIN; FAILURE;
D O I：
10.1093/cid/ciu1146
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：969 / +
页数：2
相关论文
共 10 条
[1]   Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis [J].
Alffenaar, J. W. C. ;
van Altena, R. ;
Bokkerink, H. J. ;
Luijckx, G. J. ;
van Soolingen, D. ;
Aarnoutse, R. E. ;
van der Werf, T. S. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (07) :1080-1082
[2]   Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis [J].
Cegielski, J. Peter ;
Dalton, Tracy ;
Yagui, Martin ;
Wattanaamornkiet, Wanpen ;
Volchenkov, Grigory V. ;
Via, Laura E. ;
Van der Walt, Martie ;
Tupasi, Thelma ;
Smith, Sarah E. ;
Odendaal, Ronel ;
Leimane, Vaira ;
Kvasnovsky, Charlotte ;
Kuznetsova, Tatiana ;
Kurbatova, Ekaterina ;
Kummik, Tiina ;
Kuksa, Liga ;
Kliiman, Kai ;
Kiryanova, Elena V. ;
Kim, HeeJin ;
Kim, Chang-ki ;
Kazennyy, Boris Y. ;
Jou, Ruwen ;
Huang, Wei-Lun ;
Ershova, Julia ;
Erokhin, Vladislav V. ;
Diem, Lois ;
Contreras, Carmen ;
Cho, Sang Nae ;
Chernousova, Larisa N. ;
Chen, Michael P. ;
Campos Caoili, Janice ;
Bayona, Jaime ;
Akksilp, Somsak .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (08) :1049-1063
[3]   Treatment for Multidrug-Resistant Tuberculosis: It's Worse Than We Thought! [J].
Daley, Charles L. ;
Horsburgh, C. Robert, Jr. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (08) :1064-1065
[4]   Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance [J].
Gumbo, T ;
Louie, A ;
Deziel, MR ;
Drusano, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3178-3181
[5]   Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling [J].
Gumbo, T ;
Louie, A ;
Deziel, MR ;
Parsons, LM ;
Salfinger, M ;
Drusano, GL .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1642-1651
[6]   Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy [J].
Pasipanodya, Jotam G. ;
Srivastava, Shashikant ;
Gumbo, Tawanda .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (02) :169-177
[7]   Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience [J].
Pranger, A. D. ;
van Altena, R. ;
Aarnoutse, R. E. ;
van Soolingen, D. ;
Uges, D. R. A. ;
Kosterink, J. G. W. ;
van der Werf, T. S. ;
Alffenaar, J. W. C. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) :888-894
[8]   Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial [J].
Ruslami, Rovina ;
Ganiem, A. Rizal ;
Dian, Sofiati ;
Apriani, Lika ;
Achmad, Tri Hanggono ;
van der Ven, Andre J. ;
Borm, George ;
Aarnoutse, Rob E. ;
van Crevel, Reinout .
LANCET INFECTIOUS DISEASES, 2013, 13 (01) :27-35
[9]   Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability [J].
Srivastava, Shashikant ;
Pasipanodya, Jotam G. ;
Meek, Claudia ;
Leff, Richard ;
Gumbo, Tawanda .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (12) :1951-1959
[10]   Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume [J].
Vu, D. H. ;
Koster, R. A. ;
Alffenaar, J. W. C. ;
Brouwers, J. R. B. J. ;
Uges, D. R. A. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (15-16) :1063-1070
1